

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 5.45490601 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 5.45490601 |
| 3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.28143840 |
| 4 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.16837501 |
| 5 | protein retention in ER lumen (GO:0006621) | 4.05778244 |
| 6 | detection of molecule of bacterial origin (GO:0032490) | 3.87768787 |
| 7 | exocrine pancreas development (GO:0031017) | 3.78757141 |
| 8 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.67612158 |
| 9 | negative regulation of complement activation (GO:0045916) | 3.60607450 |
| 10 | COPII vesicle coating (GO:0048208) | 3.49235422 |
| 11 | peptide hormone processing (GO:0016486) | 3.47113225 |
| 12 | endocrine pancreas development (GO:0031018) | 3.38216484 |
| 13 | iron ion import (GO:0097286) | 3.29678759 |
| 14 | protein maturation by protein folding (GO:0022417) | 3.28712391 |
| 15 | negative regulation of protein activation cascade (GO:2000258) | 3.24183683 |
| 16 | microglial cell activation (GO:0001774) | 3.20925408 |
| 17 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.20300350 |
| 18 | macroautophagy (GO:0016236) | 3.18518495 |
| 19 | negative regulation of humoral immune response (GO:0002921) | 3.15314990 |
| 20 | ER overload response (GO:0006983) | 3.13616270 |
| 21 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.09051921 |
| 22 | regulation of memory T cell differentiation (GO:0043380) | 3.07931407 |
| 23 | protein targeting to Golgi (GO:0000042) | 3.05209510 |
| 24 | cellular extravasation (GO:0045123) | 3.03886059 |
| 25 | sequestering of metal ion (GO:0051238) | 3.02888916 |
| 26 | import into cell (GO:0098657) | 3.01937011 |
| 27 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.01773284 |
| 28 | regulation of platelet aggregation (GO:0090330) | 2.99572239 |
| 29 | detection of calcium ion (GO:0005513) | 2.97513854 |
| 30 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.96694498 |
| 31 | positive regulation of nuclease activity (GO:0032075) | 2.92753775 |
| 32 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.91592194 |
| 33 | toxin metabolic process (GO:0009404) | 2.86920136 |
| 34 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.86035093 |
| 35 | vesicle coating (GO:0006901) | 2.85506525 |
| 36 | neutrophil activation involved in immune response (GO:0002283) | 2.85063583 |
| 37 | relaxation of smooth muscle (GO:0044557) | 2.84874385 |
| 38 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.84672650 |
| 39 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.84672650 |
| 40 | modulation by symbiont of host immune response (GO:0052553) | 2.84672650 |
| 41 | positive regulation by symbiont of host defense response (GO:0052509) | 2.84672650 |
| 42 | modulation by symbiont of host defense response (GO:0052031) | 2.84672650 |
| 43 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.84672650 |
| 44 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.84085393 |
| 45 | establishment of protein localization to Golgi (GO:0072600) | 2.78524964 |
| 46 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.77414139 |
| 47 | detection of external biotic stimulus (GO:0098581) | 2.76335281 |
| 48 | insulin secretion (GO:0030073) | 2.76104241 |
| 49 | signal peptide processing (GO:0006465) | 2.74527586 |
| 50 | regulation of beta-amyloid formation (GO:1902003) | 2.72564418 |
| 51 | protein localization to Golgi apparatus (GO:0034067) | 2.70091622 |
| 52 | positive regulation of insulin secretion (GO:0032024) | 2.68702655 |
| 53 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.66100810 |
| 54 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.64237752 |
| 55 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.62301215 |
| 56 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.62187478 |
| 57 | cellular response to unfolded protein (GO:0034620) | 2.60066515 |
| 58 | negative regulation of cell killing (GO:0031342) | 2.59622897 |
| 59 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.59622897 |
| 60 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.58486172 |
| 61 | L-phenylalanine catabolic process (GO:0006559) | 2.58486172 |
| 62 | regulation of nuclease activity (GO:0032069) | 2.58465624 |
| 63 | macrophage activation (GO:0042116) | 2.58371571 |
| 64 | regulation of platelet activation (GO:0010543) | 2.56708756 |
| 65 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.55955493 |
| 66 | positive regulation of glycolytic process (GO:0045821) | 2.55775771 |
| 67 | ER-nucleus signaling pathway (GO:0006984) | 2.55673825 |
| 68 | regulation of insulin secretion (GO:0050796) | 2.54245604 |
| 69 | intestinal cholesterol absorption (GO:0030299) | 2.54102833 |
| 70 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.49802904 |
| 71 | neutrophil mediated immunity (GO:0002446) | 2.48766979 |
| 72 | cellular response to topologically incorrect protein (GO:0035967) | 2.48551099 |
| 73 | type B pancreatic cell development (GO:0003323) | 2.48382494 |
| 74 | macrophage activation involved in immune response (GO:0002281) | 2.48363987 |
| 75 | transcytosis (GO:0045056) | 2.48189191 |
| 76 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.44698260 |
| 77 | glandular epithelial cell differentiation (GO:0002067) | 2.44298793 |
| 78 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.42236737 |
| 79 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.39699324 |
| 80 | response to endoplasmic reticulum stress (GO:0034976) | 2.38990323 |
| 81 | synaptic vesicle maturation (GO:0016188) | 2.36932035 |
| 82 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.36284924 |
| 83 | activation of protein kinase A activity (GO:0034199) | 2.34251777 |
| 84 | detection of other organism (GO:0098543) | 2.32859830 |
| 85 | valine metabolic process (GO:0006573) | 2.31812961 |
| 86 | regulation of peptide hormone secretion (GO:0090276) | 2.30860223 |
| 87 | positive regulation of exocytosis (GO:0045921) | 2.29788528 |
| 88 | regulation of peptide secretion (GO:0002791) | 2.29526399 |
| 89 | nitric oxide mediated signal transduction (GO:0007263) | 2.29512400 |
| 90 | positive regulation of peptide secretion (GO:0002793) | 2.28956426 |
| 91 | regulation of synaptic vesicle transport (GO:1902803) | 2.28590764 |
| 92 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.28558720 |
| 93 | positive regulation of peptide hormone secretion (GO:0090277) | 2.28493300 |
| 94 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.27918858 |
| 95 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.27564127 |
| 96 | neutrophil activation (GO:0042119) | 2.27516709 |
| 97 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.27156523 |
| 98 | cellular response to glucagon stimulus (GO:0071377) | 2.27010964 |
| 99 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.26106281 |
| 100 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.25499548 |
| 101 | L-phenylalanine metabolic process (GO:0006558) | 2.25499548 |
| 102 | detection of biotic stimulus (GO:0009595) | 2.25152691 |
| 103 | negative regulation of digestive system process (GO:0060457) | 2.23611981 |
| 104 | regulation of mast cell activation (GO:0033003) | 2.23168354 |
| 105 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.22345808 |
| 106 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.21944266 |
| 107 | chemosensory behavior (GO:0007635) | 2.21887825 |
| 108 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.20310483 |
| 109 | regulation of ARF protein signal transduction (GO:0032012) | 2.20301290 |
| 110 | keratan sulfate catabolic process (GO:0042340) | 2.19433510 |
| 111 | negative regulation of interleukin-17 production (GO:0032700) | 2.19396297 |
| 112 | glandular epithelial cell development (GO:0002068) | 2.19370097 |
| 113 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.18597876 |
| 114 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.18230824 |
| 115 | positive regulation of receptor recycling (GO:0001921) | 2.17631060 |
| 116 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.16551923 |
| 117 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.16325034 |
| 118 | peptidyl-asparagine modification (GO:0018196) | 2.15991168 |
| 119 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.15840862 |
| 120 | response to dietary excess (GO:0002021) | 2.15078372 |
| 121 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.14466308 |
| 122 | growth hormone secretion (GO:0030252) | 2.14370085 |
| 123 | peptide secretion (GO:0002790) | 2.12889234 |
| 124 | potassium ion import (GO:0010107) | 2.12846373 |
| 125 | peptide hormone secretion (GO:0030072) | 2.12706941 |
| 126 | positive regulation of vesicle fusion (GO:0031340) | 2.12498945 |
| 127 | myeloid leukocyte mediated immunity (GO:0002444) | 2.12280806 |
| 128 | tricarboxylic acid metabolic process (GO:0072350) | 2.12189745 |
| 129 | digestion (GO:0007586) | 2.12084315 |
| 130 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.11851781 |
| 131 | negative regulation of platelet activation (GO:0010544) | 2.11640698 |
| 132 | positive regulation of mast cell activation (GO:0033005) | 2.11278865 |
| 133 | response to unfolded protein (GO:0006986) | 2.10662651 |
| 134 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.10565653 |
| 135 | response to host immune response (GO:0052572) | 2.10565653 |
| 136 | Golgi organization (GO:0007030) | 2.10329295 |
| 137 | regulation of macrophage cytokine production (GO:0010935) | 2.09973808 |
| 138 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.09940638 |
| 139 | magnesium ion transport (GO:0015693) | 2.09263260 |
| 140 | branched-chain amino acid metabolic process (GO:0009081) | 2.08910746 |
| 141 | membrane repolarization during action potential (GO:0086011) | 2.08140420 |
| 142 | synaptic vesicle exocytosis (GO:0016079) | 2.07385766 |
| 143 | superoxide anion generation (GO:0042554) | 2.07119033 |
| 144 | negative regulation of inclusion body assembly (GO:0090084) | 2.07030123 |
| 145 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.06927088 |
| 146 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.06560628 |
| 147 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.06511165 |
| 148 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.05711867 |
| 149 | regulation of mast cell degranulation (GO:0043304) | 2.05260769 |
| 150 | retinal metabolic process (GO:0042574) | 2.03658058 |
| 151 | response to topologically incorrect protein (GO:0035966) | 2.03596469 |
| 152 | negative regulation of protein autophosphorylation (GO:0031953) | 2.03273358 |
| 153 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.03122130 |
| 154 | endoplasmic reticulum organization (GO:0007029) | 2.02902216 |
| 155 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.02565313 |
| 156 | regulation of exocytosis (GO:0017157) | 2.01952452 |
| 157 | negative regulation of B cell mediated immunity (GO:0002713) | 2.01875155 |
| 158 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.01875155 |
| 159 | cGMP-mediated signaling (GO:0019934) | 2.01828598 |
| 160 | cellular response to ethanol (GO:0071361) | 2.01783721 |
| 161 | positive regulation of muscle hypertrophy (GO:0014742) | 2.01675023 |
| 162 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.01675023 |
| 163 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.01635092 |
| 164 | negative regulation of catecholamine secretion (GO:0033604) | 2.01158946 |
| 165 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.00946414 |
| 166 | regulation of hormone secretion (GO:0046883) | 2.00588338 |
| 167 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.00285248 |
| 168 | early endosome to late endosome transport (GO:0045022) | 2.00196104 |
| 169 | suckling behavior (GO:0001967) | 1.99752492 |
| 170 | response to pheromone (GO:0019236) | 1.99397768 |
| 171 | diterpenoid biosynthetic process (GO:0016102) | 1.99245466 |
| 172 | phagocytosis, recognition (GO:0006910) | 1.99129796 |
| 173 | protein N-linked glycosylation (GO:0006487) | 1.99101447 |
| 174 | positive regulation of macrophage differentiation (GO:0045651) | 1.98996591 |
| 175 | branched-chain amino acid catabolic process (GO:0009083) | 1.98532589 |
| 176 | succinate metabolic process (GO:0006105) | 1.98275132 |
| 177 | response to host (GO:0075136) | 1.98060221 |
| 178 | response to host defenses (GO:0052200) | 1.98060221 |
| 179 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 1.98060221 |
| 180 | dendritic cell migration (GO:0036336) | 1.97194242 |
| 181 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 1.96839868 |
| 182 | hypotonic response (GO:0006971) | 1.95781112 |
| 183 | regulation of B cell receptor signaling pathway (GO:0050855) | 1.95262323 |
| 184 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 1.94624114 |
| 185 | granulocyte activation (GO:0036230) | 1.92939911 |
| 186 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 1.92395537 |
| 187 | regulation of interleukin-8 secretion (GO:2000482) | 1.90732367 |
| 188 | regulation of lipoprotein metabolic process (GO:0050746) | 1.90103712 |
| 189 | L-fucose catabolic process (GO:0042355) | 1.90013519 |
| 190 | fucose catabolic process (GO:0019317) | 1.90013519 |
| 191 | L-fucose metabolic process (GO:0042354) | 1.90013519 |
| 192 | negative regulation of response to reactive oxygen species (GO:1901032) | 1.89764286 |
| 193 | relaxation of muscle (GO:0090075) | 1.89490157 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.89403700 |
| 2 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.59959480 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.30351329 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.21975692 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.18040493 |
| 6 | GATA1_22025678_ChIP-Seq_K562_Human | 2.05619814 |
| 7 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.04982788 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.02967520 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.96259270 |
| 10 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.84385801 |
| 11 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.80076791 |
| 12 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.76746126 |
| 13 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.72666839 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.71451932 |
| 15 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.69511888 |
| 16 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.69105536 |
| 17 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.67193962 |
| 18 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.66723599 |
| 19 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.62707551 |
| 20 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.61826412 |
| 21 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.56996406 |
| 22 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.56647036 |
| 23 | CJUN_26792858_Chip-Seq_BT549_Human | 1.55210260 |
| 24 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.54683080 |
| 25 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.54156020 |
| 26 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.51585359 |
| 27 | TP53_16413492_ChIP-PET_HCT116_Human | 1.51322305 |
| 28 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.48367005 |
| 29 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.47850158 |
| 30 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.47463470 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.46033909 |
| 32 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.44516740 |
| 33 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.42454793 |
| 34 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.39089888 |
| 35 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.38943066 |
| 36 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.37966004 |
| 37 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.37827206 |
| 38 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.34494921 |
| 39 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.34460719 |
| 40 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33506001 |
| 41 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.33448977 |
| 42 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.32923821 |
| 43 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.32126032 |
| 44 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.31441744 |
| 45 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.31220598 |
| 46 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.29296433 |
| 47 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.28395174 |
| 48 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.28152810 |
| 49 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.27723404 |
| 50 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.26847110 |
| 51 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.26214590 |
| 52 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.24069271 |
| 53 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.23961495 |
| 54 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.23778747 |
| 55 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.23061214 |
| 56 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.23054346 |
| 57 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.21468745 |
| 58 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.21207421 |
| 59 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.17658696 |
| 60 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.15812141 |
| 61 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.15224103 |
| 62 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.14676920 |
| 63 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.14606319 |
| 64 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.14267282 |
| 65 | STAT3_23295773_ChIP-Seq_U87_Human | 1.13710567 |
| 66 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.13299054 |
| 67 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.13061997 |
| 68 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.12928346 |
| 69 | SPI1_23127762_ChIP-Seq_K562_Human | 1.11638613 |
| 70 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10938523 |
| 71 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.10353398 |
| 72 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.10316284 |
| 73 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.10250700 |
| 74 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.10250700 |
| 75 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.09271072 |
| 76 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.08416461 |
| 77 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.08365526 |
| 78 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.08031583 |
| 79 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.07496273 |
| 80 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.06800736 |
| 81 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.06628340 |
| 82 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.05536208 |
| 83 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.04525212 |
| 84 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.04278841 |
| 85 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04083892 |
| 86 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.03625706 |
| 87 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.03229737 |
| 88 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.03185302 |
| 89 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.02763161 |
| 90 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.02758345 |
| 91 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.02555981 |
| 92 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.01964284 |
| 93 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.01514106 |
| 94 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.01513711 |
| 95 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.00829671 |
| 96 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.00508288 |
| 97 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.00385278 |
| 98 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00232715 |
| 99 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.99851065 |
| 100 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.98612875 |
| 101 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.98552997 |
| 102 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.95756161 |
| 103 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.95581215 |
| 104 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.95556148 |
| 105 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.95065140 |
| 106 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.95029507 |
| 107 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.94857378 |
| 108 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.94661426 |
| 109 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.94661426 |
| 110 | AR_25329375_ChIP-Seq_VCAP_Human | 0.94566809 |
| 111 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.93930211 |
| 112 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.93479847 |
| 113 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.93365496 |
| 114 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.93305489 |
| 115 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.93305489 |
| 116 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.93271248 |
| 117 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.93265482 |
| 118 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.92957127 |
| 119 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.92587019 |
| 120 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92387168 |
| 121 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.91523194 |
| 122 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.91155238 |
| 123 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91070165 |
| 124 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.90711429 |
| 125 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.89571670 |
| 126 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89497672 |
| 127 | * AR_19668381_ChIP-Seq_PC3_Human | 0.88901177 |
| 128 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.88134164 |
| 129 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.88064153 |
| 130 | GATA1_19941826_ChIP-Seq_K562_Human | 0.88006102 |
| 131 | TCF4_23295773_ChIP-Seq_U87_Human | 0.87106209 |
| 132 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.86547468 |
| 133 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.86463733 |
| 134 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.85243731 |
| 135 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.84401599 |
| 136 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.82728254 |
| 137 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.82165908 |
| 138 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.81949265 |
| 139 | P300_19829295_ChIP-Seq_ESCs_Human | 0.81716650 |
| 140 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.81540496 |
| 141 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.80294748 |
| 142 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.80020370 |
| 143 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.79985131 |
| 144 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79115558 |
| 145 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.78055171 |
| 146 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.77141078 |
| 147 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.77001022 |
| 148 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.75568979 |
| 149 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.75568979 |
| 150 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.75115447 |
| 151 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.74901489 |
| 152 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.74817894 |
| 153 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.74715284 |
| 154 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.74676932 |
| 155 | VDR_22108803_ChIP-Seq_LS180_Human | 0.74481034 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.15930997 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 3.74204420 |
| 3 | MP0002909_abnormal_adrenal_gland | 3.49193173 |
| 4 | MP0000569_abnormal_digit_pigmentation | 3.41370464 |
| 5 | MP0004043_abnormal_pH_regulation | 3.22611469 |
| 6 | MP0009780_abnormal_chondrocyte_physiolo | 3.05620827 |
| 7 | MP0003183_abnormal_peptide_metabolism | 3.02702766 |
| 8 | MP0000013_abnormal_adipose_tissue | 2.98927788 |
| 9 | MP0003195_calcinosis | 2.67909945 |
| 10 | MP0005365_abnormal_bile_salt | 2.66752238 |
| 11 | MP0002693_abnormal_pancreas_physiology | 2.54685911 |
| 12 | MP0010386_abnormal_urinary_bladder | 2.54278777 |
| 13 | MP0008438_abnormal_cutaneous_collagen | 2.49099405 |
| 14 | MP0003828_pulmonary_edema | 2.41485588 |
| 15 | MP0001944_abnormal_pancreas_morphology | 2.31262302 |
| 16 | MP0008004_abnormal_stomach_pH | 2.30923462 |
| 17 | MP0004084_abnormal_cardiac_muscle | 2.27498405 |
| 18 | MP0005464_abnormal_platelet_physiology | 2.23116703 |
| 19 | MP0004270_analgesia | 2.07585269 |
| 20 | MP0001666_abnormal_nutrient_absorption | 2.07528095 |
| 21 | MP0005379_endocrine/exocrine_gland_phen | 2.04745741 |
| 22 | MP0005058_abnormal_lysosome_morphology | 2.03382845 |
| 23 | MP0005164_abnormal_response_to | 1.98066036 |
| 24 | MP0005220_abnormal_exocrine_pancreas | 1.97706738 |
| 25 | MP0004484_altered_response_of | 1.96391109 |
| 26 | MP0001958_emphysema | 1.92162652 |
| 27 | MP0005646_abnormal_pituitary_gland | 1.91536373 |
| 28 | MP0002877_abnormal_melanocyte_morpholog | 1.90356448 |
| 29 | MP0002078_abnormal_glucose_homeostasis | 1.87406114 |
| 30 | MP0001765_abnormal_ion_homeostasis | 1.86656123 |
| 31 | MP0004883_abnormal_blood_vessel | 1.80687814 |
| 32 | MP0002132_abnormal_respiratory_system | 1.78692172 |
| 33 | MP0003329_amyloid_beta_deposits | 1.77051103 |
| 34 | MP0003172_abnormal_lysosome_physiology | 1.76030793 |
| 35 | MP0003283_abnormal_digestive_organ | 1.72042340 |
| 36 | MP0000343_altered_response_to | 1.70867690 |
| 37 | MP0003303_peritoneal_inflammation | 1.70813897 |
| 38 | MP0004859_abnormal_synaptic_plasticity | 1.68920710 |
| 39 | MP0005083_abnormal_biliary_tract | 1.65109976 |
| 40 | MP0002419_abnormal_innate_immunity | 1.64285302 |
| 41 | MP0002139_abnormal_hepatobiliary_system | 1.62592484 |
| 42 | MP0005645_abnormal_hypothalamus_physiol | 1.61612205 |
| 43 | MP0003868_abnormal_feces_composition | 1.61015715 |
| 44 | MP0005085_abnormal_gallbladder_physiolo | 1.58151987 |
| 45 | MP0000003_abnormal_adipose_tissue | 1.55327114 |
| 46 | MP0003191_abnormal_cellular_cholesterol | 1.53079078 |
| 47 | MP0003252_abnormal_bile_duct | 1.51262617 |
| 48 | MP0001835_abnormal_antigen_presentation | 1.51182390 |
| 49 | MP0006054_spinal_hemorrhage | 1.49521192 |
| 50 | MP0009785_altered_susceptibility_to | 1.48630309 |
| 51 | MP0005535_abnormal_body_temperature | 1.48584078 |
| 52 | MP0003635_abnormal_synaptic_transmissio | 1.48254308 |
| 53 | MP0003656_abnormal_erythrocyte_physiolo | 1.45106018 |
| 54 | MP0010368_abnormal_lymphatic_system | 1.40401265 |
| 55 | MP0000465_gastrointestinal_hemorrhage | 1.40115681 |
| 56 | MP0005174_abnormal_tail_pigmentation | 1.39600694 |
| 57 | MP0008961_abnormal_basal_metabolism | 1.39391121 |
| 58 | MP0003300_gastrointestinal_ulcer | 1.39322739 |
| 59 | MP0005503_abnormal_tendon_morphology | 1.38404775 |
| 60 | MP0005275_abnormal_skin_tensile | 1.38347122 |
| 61 | MP0004130_abnormal_muscle_cell | 1.38253491 |
| 62 | MP0002734_abnormal_mechanical_nocicepti | 1.36960119 |
| 63 | MP0001533_abnormal_skeleton_physiology | 1.36002034 |
| 64 | MP0008875_abnormal_xenobiotic_pharmacok | 1.35741782 |
| 65 | MP0009643_abnormal_urine_homeostasis | 1.30968547 |
| 66 | MP0004264_abnormal_extraembryonic_tissu | 1.30443330 |
| 67 | MP0002876_abnormal_thyroid_physiology | 1.29796907 |
| 68 | MP0002295_abnormal_pulmonary_circulatio | 1.29504410 |
| 69 | MP0002118_abnormal_lipid_homeostasis | 1.29070776 |
| 70 | MP0005670_abnormal_white_adipose | 1.28059474 |
| 71 | MP0005332_abnormal_amino_acid | 1.27521327 |
| 72 | MP0003436_decreased_susceptibility_to | 1.27275721 |
| 73 | MP0003953_abnormal_hormone_level | 1.26200065 |
| 74 | MP0006072_abnormal_retinal_apoptosis | 1.26015934 |
| 75 | MP0003633_abnormal_nervous_system | 1.24783111 |
| 76 | MP0001879_abnormal_lymphatic_vessel | 1.24270148 |
| 77 | MP0002733_abnormal_thermal_nociception | 1.24140506 |
| 78 | MP0003806_abnormal_nucleotide_metabolis | 1.21894534 |
| 79 | MP0002064_seizures | 1.20939952 |
| 80 | MP0000685_abnormal_immune_system | 1.19735513 |
| 81 | MP0004145_abnormal_muscle_electrophysio | 1.19498401 |
| 82 | MP0006082_CNS_inflammation | 1.19080891 |
| 83 | MP0004036_abnormal_muscle_relaxation | 1.18794875 |
| 84 | MP0001970_abnormal_pain_threshold | 1.18390089 |
| 85 | MP0000678_abnormal_parathyroid_gland | 1.18239324 |
| 86 | MP0001756_abnormal_urination | 1.17974437 |
| 87 | MP0003075_altered_response_to | 1.16449665 |
| 88 | MP0002998_abnormal_bone_remodeling | 1.16225902 |
| 89 | MP0002272_abnormal_nervous_system | 1.15552489 |
| 90 | MP0008775_abnormal_heart_ventricle | 1.15419947 |
| 91 | MP0004272_abnormal_basement_membrane | 1.14741097 |
| 92 | MP0005636_abnormal_mineral_homeostasis | 1.13164487 |
| 93 | MP0000230_abnormal_systemic_arterial | 1.08623689 |
| 94 | MP0003279_aneurysm | 1.08189567 |
| 95 | MP0009745_abnormal_behavioral_response | 1.08065812 |
| 96 | MP0002063_abnormal_learning/memory/cond | 1.07026090 |
| 97 | MP0002822_catalepsy | 1.06696946 |
| 98 | MP0005388_respiratory_system_phenotype | 1.06309279 |
| 99 | MP0002133_abnormal_respiratory_system | 1.06309279 |
| 100 | MP0002896_abnormal_bone_mineralization | 1.05579175 |
| 101 | MP0002638_abnormal_pupillary_reflex | 1.05204335 |
| 102 | MP0004215_abnormal_myocardial_fiber | 1.04668245 |
| 103 | MP0005025_abnormal_response_to | 1.03787239 |
| 104 | MP0003045_fibrosis | 1.03600953 |
| 105 | MP0010329_abnormal_lipoprotein_level | 1.03562641 |
| 106 | MP0001502_abnormal_circadian_rhythm | 1.02830915 |
| 107 | MP0005167_abnormal_blood-brain_barrier | 1.02729479 |
| 108 | MP0002148_abnormal_hypersensitivity_rea | 1.02724770 |
| 109 | MP0002572_abnormal_emotion/affect_behav | 1.02075535 |
| 110 | MP0002735_abnormal_chemical_nociception | 1.01797787 |
| 111 | MP0005387_immune_system_phenotype | 1.01743276 |
| 112 | MP0001790_abnormal_immune_system | 1.01743276 |
| 113 | MP0001986_abnormal_taste_sensitivity | 1.01685150 |
| 114 | MP0003959_abnormal_lean_body | 1.00765351 |
| 115 | MP0001984_abnormal_olfaction | 1.00583161 |
| 116 | MP0003690_abnormal_glial_cell | 0.99792886 |
| 117 | MP0009840_abnormal_foam_cell | 0.99743045 |
| 118 | MP0005448_abnormal_energy_balance | 0.99354343 |
| 119 | MP0005310_abnormal_salivary_gland | 0.99064041 |
| 120 | MP0000604_amyloidosis | 0.99015098 |
| 121 | MP0005375_adipose_tissue_phenotype | 0.98575112 |
| 122 | MP0002928_abnormal_bile_duct | 0.98225895 |
| 123 | MP0001845_abnormal_inflammatory_respons | 0.96937842 |
| 124 | MP0001661_extended_life_span | 0.95943634 |
| 125 | MP0005165_increased_susceptibility_to | 0.95451859 |
| 126 | MP0005595_abnormal_vascular_smooth | 0.95293471 |
| 127 | MP0002168_other_aberrant_phenotype | 0.95010427 |
| 128 | MP0004885_abnormal_endolymph | 0.93810203 |
| 129 | MP0000749_muscle_degeneration | 0.93749247 |
| 130 | MP0006276_abnormal_autonomic_nervous | 0.93626798 |
| 131 | MP0002138_abnormal_hepatobiliary_system | 0.93028807 |
| 132 | MP0009764_decreased_sensitivity_to | 0.92993783 |
| 133 | MP0005166_decreased_susceptibility_to | 0.92515937 |
| 134 | MP0000920_abnormal_myelination | 0.92177669 |
| 135 | MP0000639_abnormal_adrenal_gland | 0.92128535 |
| 136 | MP0003879_abnormal_hair_cell | 0.91953792 |
| 137 | MP0002229_neurodegeneration | 0.91926432 |
| 138 | MP0004019_abnormal_vitamin_homeostasis | 0.91819630 |
| 139 | MP0000747_muscle_weakness | 0.91666036 |
| 140 | MP0008569_lethality_at_weaning | 0.91386847 |
| 141 | MP0003122_maternal_imprinting | 0.91005002 |
| 142 | MP0002234_abnormal_pharynx_morphology | 0.89785920 |
| 143 | MP0000015_abnormal_ear_pigmentation | 0.89776627 |
| 144 | MP0001968_abnormal_touch/_nociception | 0.89114509 |
| 145 | MP0000249_abnormal_blood_vessel | 0.89057984 |
| 146 | MP0001664_abnormal_digestion | 0.88700115 |
| 147 | MP0001501_abnormal_sleep_pattern | 0.87919613 |
| 148 | MP0002723_abnormal_immune_serum | 0.87656717 |
| 149 | MP0005000_abnormal_immune_tolerance | 0.87483571 |
| 150 | MP0002332_abnormal_exercise_endurance | 0.86344087 |
| 151 | MP0008874_decreased_physiological_sensi | 0.85468357 |
| 152 | MP0001542_abnormal_bone_strength | 0.85124440 |
| 153 | MP0005376_homeostasis/metabolism_phenot | 0.84280507 |
| 154 | MP0005410_abnormal_fertilization | 0.83718671 |
| 155 | MP0005084_abnormal_gallbladder_morpholo | 0.83298381 |
| 156 | MP0002452_abnormal_antigen_presenting | 0.82410691 |
| 157 | MP0003632_abnormal_nervous_system | 0.82285495 |
| 158 | MP0002069_abnormal_eating/drinking_beha | 0.80867341 |
| 159 | MP0005334_abnormal_fat_pad | 0.80578309 |
| 160 | MP0002067_abnormal_sensory_capabilities | 0.79957130 |
| 161 | MP0002277_abnormal_respiratory_mucosa | 0.79899519 |
| 162 | MP0004085_abnormal_heartbeat | 0.79601066 |
| 163 | MP0001800_abnormal_humoral_immune | 0.78204867 |
| 164 | MP0005360_urolithiasis | 0.77992937 |
| 165 | MP0003634_abnormal_glial_cell | 0.77299777 |
| 166 | MP0001851_eye_inflammation | 0.75952954 |
| 167 | MP0003631_nervous_system_phenotype | 0.75480547 |
| 168 | MP0003091_abnormal_cell_migration | 0.75034156 |
| 169 | MP0005620_abnormal_muscle_contractility | 0.74086318 |
| 170 | MP0000427_abnormal_hair_cycle | 0.73988549 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.99177435 |
| 2 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 4.66490723 |
| 3 | Hypoglycemic seizures (HP:0002173) | 4.61732306 |
| 4 | Hypoglycemic coma (HP:0001325) | 4.27132406 |
| 5 | Ketoacidosis (HP:0001993) | 4.19506050 |
| 6 | Symptomatic seizures (HP:0011145) | 4.07552372 |
| 7 | Gout (HP:0001997) | 3.69277213 |
| 8 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.57679355 |
| 9 | Dysostosis multiplex (HP:0000943) | 3.57477957 |
| 10 | Hyperglycemia (HP:0003074) | 3.48748689 |
| 11 | Mitral stenosis (HP:0001718) | 3.39243970 |
| 12 | Prolonged bleeding time (HP:0003010) | 3.38495957 |
| 13 | Visual hallucinations (HP:0002367) | 3.30313182 |
| 14 | Ketosis (HP:0001946) | 3.26586478 |
| 15 | Decreased circulating renin level (HP:0003351) | 3.24747781 |
| 16 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.20958431 |
| 17 | Absent/shortened dynein arms (HP:0200106) | 3.20958431 |
| 18 | Gingival bleeding (HP:0000225) | 3.19235108 |
| 19 | Peritonitis (HP:0002586) | 3.17544941 |
| 20 | Orchitis (HP:0100796) | 3.15125413 |
| 21 | Agitation (HP:0000713) | 3.12807951 |
| 22 | Spontaneous hematomas (HP:0007420) | 3.11140422 |
| 23 | Optic neuritis (HP:0100653) | 3.09256386 |
| 24 | Retrobulbar optic neuritis (HP:0100654) | 3.09256386 |
| 25 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.06516879 |
| 26 | Mucopolysacchariduria (HP:0008155) | 3.06516879 |
| 27 | Hyperactive renin-angiotensin system (HP:0000841) | 3.06448760 |
| 28 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.02993830 |
| 29 | Abnormal ciliary motility (HP:0012262) | 3.01433226 |
| 30 | Myositis (HP:0100614) | 2.99160410 |
| 31 | Aortic aneurysm (HP:0004942) | 2.98603756 |
| 32 | Increased circulating renin level (HP:0000848) | 2.95751165 |
| 33 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.95742925 |
| 34 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.95742925 |
| 35 | Hyporeflexia of lower limbs (HP:0002600) | 2.95485620 |
| 36 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.94563286 |
| 37 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.94563286 |
| 38 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.94563286 |
| 39 | Abnormality of renin-angiotensin system (HP:0000847) | 2.91041429 |
| 40 | Late onset (HP:0003584) | 2.86591183 |
| 41 | Eczematoid dermatitis (HP:0000976) | 2.86142715 |
| 42 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.85752620 |
| 43 | Large for gestational age (HP:0001520) | 2.84822684 |
| 44 | Hyperkalemia (HP:0002153) | 2.81694629 |
| 45 | Stomatitis (HP:0010280) | 2.79659746 |
| 46 | Hypokalemia (HP:0002900) | 2.78882550 |
| 47 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.76978896 |
| 48 | Recurrent abscess formation (HP:0002722) | 2.73864744 |
| 49 | Neurofibrillary tangles (HP:0002185) | 2.70924689 |
| 50 | Recurrent bacterial skin infections (HP:0005406) | 2.66894908 |
| 51 | Retinal atrophy (HP:0001105) | 2.63319010 |
| 52 | Abnormality of potassium homeostasis (HP:0011042) | 2.61802559 |
| 53 | Conjugated hyperbilirubinemia (HP:0002908) | 2.59641683 |
| 54 | Menorrhagia (HP:0000132) | 2.58891791 |
| 55 | Abnormality of macrophages (HP:0004311) | 2.57303225 |
| 56 | Epistaxis (HP:0000421) | 2.54182848 |
| 57 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.53967441 |
| 58 | Hypokalemic alkalosis (HP:0001949) | 2.53536522 |
| 59 | Abnormality of the intrinsic pathway (HP:0010989) | 2.51012408 |
| 60 | Generalized aminoaciduria (HP:0002909) | 2.48363725 |
| 61 | Vascular tortuosity (HP:0004948) | 2.43882968 |
| 62 | Hyperlipoproteinemia (HP:0010980) | 2.43203268 |
| 63 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.42750542 |
| 64 | Hematochezia (HP:0002573) | 2.42093503 |
| 65 | Papilledema (HP:0001085) | 2.42090536 |
| 66 | Pheochromocytoma (HP:0002666) | 2.41875775 |
| 67 | Abnormality of chloride homeostasis (HP:0011422) | 2.39233638 |
| 68 | Aortic dissection (HP:0002647) | 2.38473313 |
| 69 | Hypothermia (HP:0002045) | 2.37749464 |
| 70 | Vacuolated lymphocytes (HP:0001922) | 2.35203485 |
| 71 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.34910576 |
| 72 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.34910576 |
| 73 | Episodic fever (HP:0001954) | 2.32574071 |
| 74 | Oligomenorrhea (HP:0000876) | 2.31528097 |
| 75 | Arterial tortuosity (HP:0005116) | 2.31041191 |
| 76 | Gastrointestinal infarctions (HP:0005244) | 2.28603262 |
| 77 | Cardiovascular calcification (HP:0011915) | 2.28113065 |
| 78 | Petechiae (HP:0000967) | 2.27518796 |
| 79 | Hyperaldosteronism (HP:0000859) | 2.25943680 |
| 80 | Abnormal platelet volume (HP:0011876) | 2.23129085 |
| 81 | Arterial thrombosis (HP:0004420) | 2.21971770 |
| 82 | Protuberant abdomen (HP:0001538) | 2.21311577 |
| 83 | Cerebral inclusion bodies (HP:0100314) | 2.21047600 |
| 84 | Facial diplegia (HP:0001349) | 2.20783414 |
| 85 | Supranuclear gaze palsy (HP:0000605) | 2.19485020 |
| 86 | Abnormality of purine metabolism (HP:0004352) | 2.17189724 |
| 87 | Polycythemia (HP:0001901) | 2.15971690 |
| 88 | Increased mean platelet volume (HP:0011877) | 2.15058718 |
| 89 | Generalized hypopigmentation of hair (HP:0011358) | 2.14361514 |
| 90 | Purpura (HP:0000979) | 2.13048048 |
| 91 | Striae distensae (HP:0001065) | 2.11533134 |
| 92 | Abnormality of the frontal sinuses (HP:0002687) | 2.11020824 |
| 93 | EEG with generalized epileptiform discharges (HP:0011198) | 2.09827697 |
| 94 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.09165980 |
| 95 | Abnormality of the common coagulation pathway (HP:0010990) | 2.09121379 |
| 96 | Progressive neurologic deterioration (HP:0002344) | 2.08669058 |
| 97 | Metaphyseal dysplasia (HP:0100255) | 2.07968305 |
| 98 | Rhinitis (HP:0012384) | 2.07102893 |
| 99 | Muscle fiber splitting (HP:0003555) | 2.06946328 |
| 100 | Abnormal pancreas size (HP:0012094) | 2.06410838 |
| 101 | Epileptiform EEG discharges (HP:0011182) | 2.05476792 |
| 102 | Hypsarrhythmia (HP:0002521) | 2.04792425 |
| 103 | Polydipsia (HP:0001959) | 2.04572837 |
| 104 | Abnormal drinking behavior (HP:0030082) | 2.04572837 |
| 105 | Amyloidosis (HP:0011034) | 2.03758349 |
| 106 | Spondylolisthesis (HP:0003302) | 2.03393008 |
| 107 | Failure to thrive in infancy (HP:0001531) | 2.03050398 |
| 108 | Hypotension (HP:0002615) | 2.02924122 |
| 109 | Restlessness (HP:0000711) | 2.02680073 |
| 110 | Resting tremor (HP:0002322) | 2.01686869 |
| 111 | Neuroendocrine neoplasm (HP:0100634) | 2.00670346 |
| 112 | Arthropathy (HP:0003040) | 1.98230481 |
| 113 | Metabolic alkalosis (HP:0200114) | 1.98063904 |
| 114 | Protrusio acetabuli (HP:0003179) | 1.95574540 |
| 115 | Keratoconjunctivitis sicca (HP:0001097) | 1.95516005 |
| 116 | Pulmonary embolism (HP:0002204) | 1.93520460 |
| 117 | Hyperuricemia (HP:0002149) | 1.91895347 |
| 118 | Increased purine levels (HP:0004368) | 1.91895347 |
| 119 | Growth hormone excess (HP:0000845) | 1.91792604 |
| 120 | Syncope (HP:0001279) | 1.90481132 |
| 121 | Vascular calcification (HP:0004934) | 1.90454791 |
| 122 | Tachypnea (HP:0002789) | 1.89444812 |
| 123 | Cerebral hemorrhage (HP:0001342) | 1.88675520 |
| 124 | Adrenal overactivity (HP:0002717) | 1.88255936 |
| 125 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.88089467 |
| 126 | Febrile seizures (HP:0002373) | 1.87558802 |
| 127 | Hemoptysis (HP:0002105) | 1.87311234 |
| 128 | Postural instability (HP:0002172) | 1.86869038 |
| 129 | Anxiety (HP:0000739) | 1.86400280 |
| 130 | Keratoconjunctivitis (HP:0001096) | 1.86226547 |
| 131 | Muscle fibrillation (HP:0010546) | 1.85610019 |
| 132 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.85056254 |
| 133 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.85056254 |
| 134 | Abnormality of glycolipid metabolism (HP:0010969) | 1.85056254 |
| 135 | Focal motor seizures (HP:0011153) | 1.84398667 |
| 136 | Dysautonomia (HP:0002459) | 1.84156476 |
| 137 | Clumsiness (HP:0002312) | 1.83055059 |
| 138 | Global brain atrophy (HP:0002283) | 1.82400775 |
| 139 | Fair hair (HP:0002286) | 1.80776383 |
| 140 | Hyperphosphatemia (HP:0002905) | 1.80261642 |
| 141 | Bruising susceptibility (HP:0000978) | 1.79707814 |
| 142 | Bundle branch block (HP:0011710) | 1.79268850 |
| 143 | Abnormality of renal excretion (HP:0011036) | 1.79059906 |
| 144 | Hyperglycinemia (HP:0002154) | 1.78435804 |
| 145 | Insulin resistance (HP:0000855) | 1.78305954 |
| 146 | Papillary thyroid carcinoma (HP:0002895) | 1.78300051 |
| 147 | Hyperglycinuria (HP:0003108) | 1.77966443 |
| 148 | Depression (HP:0000716) | 1.77354198 |
| 149 | Widely spaced teeth (HP:0000687) | 1.77047346 |
| 150 | Renal salt wasting (HP:0000127) | 1.76739245 |
| 151 | Hypomagnesemia (HP:0002917) | 1.75050269 |
| 152 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.74467890 |
| 153 | Asymmetric septal hypertrophy (HP:0001670) | 1.74177330 |
| 154 | Choroideremia (HP:0001139) | 1.74031868 |
| 155 | Exocrine pancreatic insufficiency (HP:0001738) | 1.73824727 |
| 156 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.73739067 |
| 157 | Menstrual irregularities (HP:0000858) | 1.73606520 |
| 158 | Alkalosis (HP:0001948) | 1.73574587 |
| 159 | Macroorchidism (HP:0000053) | 1.72826670 |
| 160 | Difficulty running (HP:0009046) | 1.72549956 |
| 161 | Abnormal urine output (HP:0012590) | 1.72472219 |
| 162 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.71696117 |
| 163 | Increased CSF protein (HP:0002922) | 1.71633272 |
| 164 | Ventricular fibrillation (HP:0001663) | 1.70713894 |
| 165 | Exercise-induced myalgia (HP:0003738) | 1.69460699 |
| 166 | Chronic bronchitis (HP:0004469) | 1.69070793 |
| 167 | Frequent falls (HP:0002359) | 1.69019224 |
| 168 | Gaze-evoked nystagmus (HP:0000640) | 1.68478294 |
| 169 | Abdominal distention (HP:0003270) | 1.68310972 |
| 170 | Polyuria (HP:0000103) | 1.68287116 |
| 171 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.68120462 |
| 172 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.67594390 |
| 173 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.67594390 |
| 174 | Increased cerebral lipofuscin (HP:0011813) | 1.66506248 |
| 175 | Myoglobinuria (HP:0002913) | 1.65980402 |
| 176 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.65788707 |
| 177 | Hyperparathyroidism (HP:0000843) | 1.65009606 |
| 178 | Pulmonary infiltrates (HP:0002113) | 1.64799161 |
| 179 | Inability to walk (HP:0002540) | 1.64719651 |
| 180 | Intrahepatic cholestasis (HP:0001406) | 1.63441155 |
| 181 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.63224889 |
| 182 | Gingivitis (HP:0000230) | 1.62225464 |
| 183 | Decreased central vision (HP:0007663) | 1.58838695 |
| 184 | Hypophosphatemic rickets (HP:0004912) | 1.58498190 |
| 185 | Impaired platelet aggregation (HP:0003540) | 1.58395569 |
| 186 | Abnormal platelet function (HP:0011869) | 1.58395569 |
| 187 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.58359210 |
| 188 | Congenital sensorineural hearing impairment (HP:0008527) | 1.57719272 |
| 189 | Conjunctival telangiectasia (HP:0000524) | 1.57708602 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 4.88425424 |
| 2 | MAPK15 | 3.31686621 |
| 3 | TAOK3 | 3.11893938 |
| 4 | WNK4 | 2.44956485 |
| 5 | NTRK3 | 2.36437877 |
| 6 | ERN1 | 2.29036777 |
| 7 | RIPK4 | 2.28207226 |
| 8 | BCKDK | 2.21583641 |
| 9 | PRKD3 | 2.21250512 |
| 10 | WNK3 | 2.13355757 |
| 11 | AKT3 | 2.01461897 |
| 12 | MYLK | 2.00378408 |
| 13 | MAP3K2 | 1.99921625 |
| 14 | FRK | 1.98021715 |
| 15 | NTRK1 | 1.87548307 |
| 16 | ACVR1B | 1.81810989 |
| 17 | BLK | 1.80373146 |
| 18 | TRPM7 | 1.79447100 |
| 19 | PIK3CG | 1.78894667 |
| 20 | PTK2B | 1.77822773 |
| 21 | CAMKK2 | 1.74229148 |
| 22 | HIPK2 | 1.62098019 |
| 23 | ADRBK2 | 1.48685429 |
| 24 | MAP3K13 | 1.46034870 |
| 25 | MAP3K1 | 1.45273758 |
| 26 | MARK3 | 1.43133607 |
| 27 | PRKCH | 1.40461841 |
| 28 | UHMK1 | 1.37671928 |
| 29 | TEC | 1.36763970 |
| 30 | BMPR1B | 1.34062959 |
| 31 | NEK9 | 1.33757444 |
| 32 | EPHB1 | 1.33499124 |
| 33 | SIK1 | 1.33202028 |
| 34 | MAP3K3 | 1.32628989 |
| 35 | CSK | 1.28526636 |
| 36 | IRAK1 | 1.26803675 |
| 37 | FES | 1.25797447 |
| 38 | PAK3 | 1.24295444 |
| 39 | FGFR4 | 1.24028130 |
| 40 | WNK1 | 1.23975492 |
| 41 | TYK2 | 1.23945165 |
| 42 | SGK223 | 1.19078289 |
| 43 | SGK494 | 1.19078289 |
| 44 | GRK6 | 1.16821025 |
| 45 | KSR1 | 1.16012729 |
| 46 | PINK1 | 1.15941177 |
| 47 | MAP2K4 | 1.15200188 |
| 48 | SIK3 | 1.10977155 |
| 49 | MAP3K9 | 1.10799545 |
| 50 | IRAK2 | 1.08503345 |
| 51 | BMPR2 | 1.08127707 |
| 52 | ADRBK1 | 1.03896505 |
| 53 | PHKG1 | 1.02756356 |
| 54 | PHKG2 | 1.02756356 |
| 55 | KSR2 | 1.02315707 |
| 56 | OXSR1 | 1.02180702 |
| 57 | PASK | 0.99644726 |
| 58 | OBSCN | 0.99278162 |
| 59 | STK38 | 0.99070266 |
| 60 | PTK2 | 0.98497917 |
| 61 | TRIB3 | 0.97618939 |
| 62 | MAP3K4 | 0.97300743 |
| 63 | FER | 0.96998974 |
| 64 | HCK | 0.95659548 |
| 65 | EPHA3 | 0.95347366 |
| 66 | YES1 | 0.94858573 |
| 67 | SGK3 | 0.94753286 |
| 68 | SGK2 | 0.93401867 |
| 69 | RET | 0.93155547 |
| 70 | PRKD2 | 0.92999276 |
| 71 | PLK2 | 0.90322885 |
| 72 | MAP3K12 | 0.89625594 |
| 73 | STK39 | 0.89111856 |
| 74 | MAP2K3 | 0.87263333 |
| 75 | KIT | 0.86706996 |
| 76 | SYK | 0.85295116 |
| 77 | GRK5 | 0.84393892 |
| 78 | BTK | 0.84116197 |
| 79 | CAMK1G | 0.83150092 |
| 80 | DAPK2 | 0.82832547 |
| 81 | DDR2 | 0.80361734 |
| 82 | PNCK | 0.79029415 |
| 83 | MAP2K7 | 0.78702424 |
| 84 | FGR | 0.78461339 |
| 85 | PRKCE | 0.78193103 |
| 86 | PAK6 | 0.78001928 |
| 87 | TRIM28 | 0.77970635 |
| 88 | PRKG2 | 0.76752421 |
| 89 | PDGFRA | 0.74020992 |
| 90 | ITK | 0.72719432 |
| 91 | MAPK12 | 0.72694622 |
| 92 | PDPK1 | 0.72608853 |
| 93 | JAK3 | 0.70827020 |
| 94 | CAMKK1 | 0.70675091 |
| 95 | PRKAA1 | 0.70482588 |
| 96 | PRKD1 | 0.70372664 |
| 97 | MUSK | 0.69793863 |
| 98 | CDK5 | 0.69708585 |
| 99 | RAF1 | 0.69570078 |
| 100 | CDC42BPA | 0.68732826 |
| 101 | JAK1 | 0.68471257 |
| 102 | PIK3CA | 0.67783128 |
| 103 | JAK2 | 0.66941984 |
| 104 | IRAK3 | 0.66566107 |
| 105 | PDK2 | 0.65642163 |
| 106 | STK11 | 0.64049522 |
| 107 | NEK6 | 0.63254841 |
| 108 | PTK6 | 0.62414756 |
| 109 | GRK1 | 0.61730371 |
| 110 | CAMK2D | 0.61324894 |
| 111 | MAP3K7 | 0.60852641 |
| 112 | LYN | 0.60838151 |
| 113 | LMTK2 | 0.60479808 |
| 114 | PDK4 | 0.59751915 |
| 115 | PDK3 | 0.59751915 |
| 116 | PRKCQ | 0.59728901 |
| 117 | PDK1 | 0.58616861 |
| 118 | FLT3 | 0.57421789 |
| 119 | MOS | 0.56333937 |
| 120 | MINK1 | 0.56110136 |
| 121 | CAMK2B | 0.54568144 |
| 122 | BCR | 0.51546500 |
| 123 | MARK2 | 0.50361399 |
| 124 | MAP3K14 | 0.50354480 |
| 125 | CAMK2A | 0.50301446 |
| 126 | MAPKAPK3 | 0.49249761 |
| 127 | TNK2 | 0.49202426 |
| 128 | TXK | 0.49190733 |
| 129 | FGFR2 | 0.48989197 |
| 130 | IRAK4 | 0.48771901 |
| 131 | PRKG1 | 0.48718434 |
| 132 | PRPF4B | 0.48209651 |
| 133 | CASK | 0.48117296 |
| 134 | PRKAA2 | 0.47534263 |
| 135 | DYRK1B | 0.47465538 |
| 136 | FGFR3 | 0.47195865 |
| 137 | STK3 | 0.46481394 |
| 138 | MAPK13 | 0.45993476 |
| 139 | TGFBR2 | 0.45906870 |
| 140 | PRKACG | 0.45745032 |
| 141 | NLK | 0.45740288 |
| 142 | MAP2K2 | 0.45695625 |
| 143 | MET | 0.44881181 |
| 144 | ROCK1 | 0.44797389 |
| 145 | SGK1 | 0.43203659 |
| 146 | PRKCG | 0.42014105 |
| 147 | PDGFRB | 0.41951090 |
| 148 | CAMK1D | 0.41047910 |
| 149 | GRK7 | 0.40192348 |
| 150 | PRKACA | 0.36692484 |
| 151 | DYRK1A | 0.36641682 |
| 152 | TIE1 | 0.36630600 |
| 153 | ZAP70 | 0.36502472 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.75686108 |
| 2 | Protein export_Homo sapiens_hsa03060 | 2.43355378 |
| 3 | Insulin secretion_Homo sapiens_hsa04911 | 2.39944763 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.15009828 |
| 5 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.88717954 |
| 6 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.86960106 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.69294041 |
| 8 | Platelet activation_Homo sapiens_hsa04611 | 1.62064875 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.60195077 |
| 10 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.57435015 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.52888231 |
| 12 | Lysosome_Homo sapiens_hsa04142 | 1.46355310 |
| 13 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.45764115 |
| 14 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.42974632 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.42107879 |
| 16 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.41323747 |
| 17 | Phagosome_Homo sapiens_hsa04145 | 1.40783557 |
| 18 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.39258684 |
| 19 | Malaria_Homo sapiens_hsa05144 | 1.35083114 |
| 20 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.27877214 |
| 21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.27692460 |
| 22 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.26476133 |
| 23 | GABAergic synapse_Homo sapiens_hsa04727 | 1.24782178 |
| 24 | Cocaine addiction_Homo sapiens_hsa05030 | 1.23123077 |
| 25 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.23064751 |
| 26 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.20326535 |
| 27 | Leishmaniasis_Homo sapiens_hsa05140 | 1.19445239 |
| 28 | Other glycan degradation_Homo sapiens_hsa00511 | 1.17139007 |
| 29 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.16405031 |
| 30 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.13935085 |
| 31 | Tuberculosis_Homo sapiens_hsa05152 | 1.13684319 |
| 32 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.13289946 |
| 33 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.12699606 |
| 34 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.12487007 |
| 35 | Taste transduction_Homo sapiens_hsa04742 | 1.10841401 |
| 36 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.10311047 |
| 37 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.08979945 |
| 38 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.08911424 |
| 39 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.07326467 |
| 40 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.06713968 |
| 41 | Circadian entrainment_Homo sapiens_hsa04713 | 1.06385050 |
| 42 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.03034987 |
| 43 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.02471356 |
| 44 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.00237874 |
| 45 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.99305006 |
| 46 | Morphine addiction_Homo sapiens_hsa05032 | 0.96953306 |
| 47 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.95881248 |
| 48 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.93800536 |
| 49 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.92890975 |
| 50 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.92840510 |
| 51 | ABC transporters_Homo sapiens_hsa02010 | 0.90300070 |
| 52 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.89572700 |
| 53 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.89360923 |
| 54 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.88762587 |
| 55 | Salivary secretion_Homo sapiens_hsa04970 | 0.87377169 |
| 56 | Renin secretion_Homo sapiens_hsa04924 | 0.86863954 |
| 57 | Circadian rhythm_Homo sapiens_hsa04710 | 0.86665112 |
| 58 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.86277151 |
| 59 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.86031883 |
| 60 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.85829039 |
| 61 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.85786534 |
| 62 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.83096651 |
| 63 | Long-term potentiation_Homo sapiens_hsa04720 | 0.83010866 |
| 64 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.82926521 |
| 65 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.82786683 |
| 66 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.82287758 |
| 67 | Insulin resistance_Homo sapiens_hsa04931 | 0.81810267 |
| 68 | Histidine metabolism_Homo sapiens_hsa00340 | 0.81726524 |
| 69 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.81459437 |
| 70 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.80877540 |
| 71 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80863290 |
| 72 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.80442213 |
| 73 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.80150714 |
| 74 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.79980814 |
| 75 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.79585167 |
| 76 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.78989193 |
| 77 | Mineral absorption_Homo sapiens_hsa04978 | 0.78944238 |
| 78 | Olfactory transduction_Homo sapiens_hsa04740 | 0.78405877 |
| 79 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.77701660 |
| 80 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.77321197 |
| 81 | Bile secretion_Homo sapiens_hsa04976 | 0.76897369 |
| 82 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.76328807 |
| 83 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.76116315 |
| 84 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.75535037 |
| 85 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.74853800 |
| 86 | Amoebiasis_Homo sapiens_hsa05146 | 0.74618995 |
| 87 | Focal adhesion_Homo sapiens_hsa04510 | 0.74449499 |
| 88 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.73634584 |
| 89 | Pertussis_Homo sapiens_hsa05133 | 0.73595973 |
| 90 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.73289018 |
| 91 | Nicotine addiction_Homo sapiens_hsa05033 | 0.72905031 |
| 92 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.72579540 |
| 93 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.72339143 |
| 94 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.71925287 |
| 95 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.71764880 |
| 96 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.71647912 |
| 97 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.71646777 |
| 98 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.71521872 |
| 99 | Prion diseases_Homo sapiens_hsa05020 | 0.71021780 |
| 100 | Gap junction_Homo sapiens_hsa04540 | 0.70879885 |
| 101 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.70414779 |
| 102 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.70267013 |
| 103 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.68782198 |
| 104 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.67766766 |
| 105 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.66894653 |
| 106 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.66523891 |
| 107 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.65841248 |
| 108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.65584043 |
| 109 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.64433480 |
| 110 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.63733115 |
| 111 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.63578072 |
| 112 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.62633647 |
| 113 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.62456899 |
| 114 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.61806332 |
| 115 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.61537786 |
| 116 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.60734092 |
| 117 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.60551303 |
| 118 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.60502570 |
| 119 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.60333543 |
| 120 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.60219804 |
| 121 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.60198105 |
| 122 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.59608283 |
| 123 | Retinol metabolism_Homo sapiens_hsa00830 | 0.59593661 |
| 124 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59199096 |
| 125 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.58112829 |
| 126 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.58046604 |
| 127 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.57658127 |
| 128 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.57371313 |
| 129 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.56442842 |
| 130 | Peroxisome_Homo sapiens_hsa04146 | 0.55640151 |
| 131 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.55595508 |
| 132 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.55593400 |
| 133 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.55588473 |
| 134 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.54529398 |
| 135 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.53858925 |
| 136 | Legionellosis_Homo sapiens_hsa05134 | 0.53171403 |
| 137 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.52736458 |
| 138 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.51895098 |
| 139 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.51836113 |
| 140 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.51539393 |
| 141 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.50576074 |
| 142 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.47074203 |
| 143 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.46164576 |
| 144 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.46149520 |
| 145 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.44355476 |
| 146 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.43798862 |
| 147 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.43273269 |
| 148 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.41524182 |
| 149 | Long-term depression_Homo sapiens_hsa04730 | 0.41045661 |
| 150 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.39951322 |
| 151 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.39664535 |
| 152 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.39545935 |
| 153 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.38905040 |
| 154 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38495152 |

